. . "18"^^ . . "32"^^ . . "2017-09-10T00:00:00Z"^^ . . . "NCT01669798" . . . . "clinical trial"@en . . . . "Phase II Evaluation of BIBF 1120 in the Treatment of Bevacizumab-Resistant, Persistent, or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma"@en . "klinisch onderzoek"@nl . . . "2013-02-01T00:00:00Z"^^ . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . "BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer"@en . . . "BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer"@en . . . "BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer"@en . . . "ensayu cl\u00EDnicu"@ast . .